Publication | Closed Access

Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells

Cancer-associated VirusMedicineAnti-erbb2 RibozymeCell BiologyCancer TreatmentTumor SuppressorOncologyRadiation OncologyGrowth Inhibition EfficacyTumor BiologyCancer GrowthDual Therapeutic Genes